Evotec SE (EVO) Depreciation & Amortization - Total (2022 - 2023)
Evotec SE's (EVO) quarterly Depreciation & Amortization - Total came in at $44.5 million in Q3 2023, up 132657.66% quarter-over-quarter from $33497.8 in Q4 2022.
Powered by 
Analysis
Evotec SE (EVO) Depreciation & Amortization - Total (2022 - 2023) Analysis & Trends
Evotec SE has disclosed Depreciation & Amortization - Total across 2 years of filings, most recently posting $44.5 million for Q3 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dep. & Amort. (Tot) (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 42.77 Bn | 40.69 Bn | 1.44 Bn | - |
| 2 | Medpace Holdings | 16.50 Bn | 16.00 Bn | 201.64 Mn | 6.56 Mn |
| 3 | Charles River Laboratories International | 13.37 Bn | 13.18 Bn | 452.07 Mn | - |
| 4 | Icon | 12.49 Bn | 11.56 Bn | 479.29 Mn | - |
| 5 | Fortrea Holdings | 1.58 Bn | 1.42 Bn | 139.20 Mn | - |
| 6 | Evotec SE | 642.83 Mn | 216.96 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 422.55 Mn | 338.02 Mn | 18.44 Mn | - |
| 8 | Champions Oncology | 69.16 Mn | 69.16 Mn | 7.03 Mn | - |
| 9 | MindWalk Holdings | 59.83 Mn | 51.55 Mn | 1.82 Mn | - |
| 10 | VivoSim Labs | 1.45 Mn | 1.45 Mn | - | - |